TRANSPHORM brings together internationally leading air
quality and health researchers and users to improve the knowledge of transport
related airborne particulate matter (PM) and its impact on human health. Furthermore, it aims to develop and implement
assessment approaches for city to European scales. TRANSPHORM’s approach
integrates emission and measurement data, air quality and exposure models and
employs the latest concentration-response functions and burden of disease
metrics to calculate the health impact resulting from airborne particulate
If you would like more information on TRANSPHORM, including the
latest results from the project, or if you would like to register as a
stakeholder, please contact us. Details
of individual partners and their contact details can be found here.
TRANSPHORM Stakeholders Meeting
On Tuesday 6th May 2014, key stakeholders were
invited to a workshop on ‘Quantifying Health Impacts of Particulate Matter over
Europe: New Approaches, Implications, and Recommendations for Policy’. Speakers from the project presented their
latest scientific findings and examined a range of adaptation and mitigation
measures to reduce health impacts of airborne particulate matter. These presentations can be found here. The meeting focused on results from recent
city and European scale case studies quantifying the health impacts for current
and future years and proposing recommendations for policy and decision making.
Key stakeholders present at the meeting included:
- European policy decision makers
- City representatives working on air quality, transport,
planning and urban planning
- Representatives from industry and environmental sectors
A full list of those present at the workshop, can be found here.
Outcomes of the Meeting
Notes on the discussions held at the meeting will be released shortly.